Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth C Anderson

Showing results (91-100 of 868) with videos related to

Pageof 87
Sort By:
Immunotherapy|September 16, 2015
Targeting B-cell maturation antigen in multiple myelomaYu-Tzu Tai, Kenneth C Anderson
Hematology. American Society of Hematology. Education Program|December 4, 2018
Approach to the treatment of the older, unfit patient with myeloma from diagnosis to relapse: perspectives of a US hematologist and a geriatric hematologistTanya M Wildes, Kenneth C Anderson
Critical Reviews in Oncology/Hematology|May 15, 2002
What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia?Richard J Benjamin, Kenneth C Anderson
Oncotarget|January 20, 2018
Targeting CD38 alleviates tumor-induced immunosuppressionYu-Tzu Tai, Kenneth C Anderson
Blood Cancer Discovery|October 18, 2021
<i>Blood Cancer Discovery</i> Turns OneRiccardo Dalla-Favera, Kenneth C Anderson
Expert Opinion on Biological Therapy|July 7, 2019
B cell maturation antigen (BCMA)-based immunotherapy for multiple myelomaYu-Tzu Tai, Kenneth C Anderson
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|July 5, 2007
Inhibition of the TGF-beta signaling pathway in tumor cellsKlaus Podar, Noopur Raje, Kenneth C Anderson
Current Treatment Options in Oncology|April 30, 2004
An update of novel therapeutic approaches for multiple myelomaPaul Richardson, Teru Hideshima, Kenneth C Anderson
Experimental Hematology|September 1, 2021
Corrigendum to <'Novel therapeutic strategies for multiple myeloma'> <[Experimental Hematology 2015; 43: 732-741]>Naoya Mimura, Teru Hideshima, Kenneth C Anderson
Reviews in Clinical and Experimental Hematology|March 6, 2003
Novel biologically based therapeutic strategies in myelomaDeepak Gupta, Teru Hideshima, Kenneth C Anderson
Pageof 87

Showing results (91-100 of 868) with videos related to

Sort By:
Pageof 87
Immunotherapy|September 16, 2015
Targeting B-cell maturation antigen in multiple myelomaYu-Tzu Tai, Kenneth C Anderson
Hematology. American Society of Hematology. Education Program|December 4, 2018
Approach to the treatment of the older, unfit patient with myeloma from diagnosis to relapse: perspectives of a US hematologist and a geriatric hematologistTanya M Wildes, Kenneth C Anderson
Critical Reviews in Oncology/Hematology|May 15, 2002
What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia?Richard J Benjamin, Kenneth C Anderson
Oncotarget|January 20, 2018
Targeting CD38 alleviates tumor-induced immunosuppressionYu-Tzu Tai, Kenneth C Anderson
Blood Cancer Discovery|October 18, 2021
<i>Blood Cancer Discovery</i> Turns OneRiccardo Dalla-Favera, Kenneth C Anderson
Expert Opinion on Biological Therapy|July 7, 2019
B cell maturation antigen (BCMA)-based immunotherapy for multiple myelomaYu-Tzu Tai, Kenneth C Anderson
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|July 5, 2007
Inhibition of the TGF-beta signaling pathway in tumor cellsKlaus Podar, Noopur Raje, Kenneth C Anderson
Current Treatment Options in Oncology|April 30, 2004
An update of novel therapeutic approaches for multiple myelomaPaul Richardson, Teru Hideshima, Kenneth C Anderson
Experimental Hematology|September 1, 2021
Corrigendum to <'Novel therapeutic strategies for multiple myeloma'> <[Experimental Hematology 2015; 43: 732-741]>Naoya Mimura, Teru Hideshima, Kenneth C Anderson
Reviews in Clinical and Experimental Hematology|March 6, 2003
Novel biologically based therapeutic strategies in myelomaDeepak Gupta, Teru Hideshima, Kenneth C Anderson
Pageof 87